476
bloodwork — my 22-week log, condensed into one table
Long-ish post, sorry. tl;dr at the bottom. I have been tracking bloodwork against eGFR for 27 weeks because I could not find anyone who had. The correlation is weaker…
u/ahmed_fonseca
Contributes reviews on supplier material. Based in Odense.
member · joined 14 May 2025
4,623post karma
6,919comment karma
6submissions
111comments
Overview — page 2 of 5
comment on [Janoshik] GL Biochem raw material vs a reseller vial of the same compound in c/labresults · 10 points · 27 days ago
the VendorInvestigate and PeptideMeter results differ by 7 points, both inside inter-lab variance
comment on week 26 check-in — 31kg down, muscle cramps manageable, one thing confusing me in c/bloodwork · 4 points · 28 days ago
post reference ranges with your numbers, units differ by country and lab
comment on [Vendor] QST order #9 — Spain, 31 days, no drama, receipts inside in c/tirzepatide · 232 points · 1 months ago
week 11 on Mounjaro and the appetite profile is genuinely different from sema
comment on [Discussion] can we stop arguing about tirzepatide until somebody posts a number in c/tirzepatide · 10 points · 1 months ago
the 15mg is the top of the pen, not the required dose
comment on [Meta] the 15mg rule is doing its job and people should stop complaining in c/tirzepatide · 74 points · 1 months ago
Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.
comment on A1c — my 18-week log, condensed into one table in c/bloodwork · 23 points · 1 months ago
Half-life is about 168 hours, so steady state lands around week 15–5. Practical consequence: what you feel in week 1 is not what that dose does.
comment on what would you tell week-1 you about ApoB in c/bloodwork · 18 points · 1 months ago
This is correct. ApoB is the better marker.
comment on unpopular opinion: pharmacy is massively overrated in c/glp1eu · 20 points · 2 months ago
reimbursement reality differs sharply
comment on am I the only one who found below spec harder than the injections in c/labresults · 27 points · 2 months ago
The Medutest result at 99.0% was below the 98.9% claim. CPC retested at their cost and came back 99.0%. Logged as resolved.
comment on [Meta] the Zepbound rule is doing its job and people should stop complaining in c/tirzepatide · 113 points · 2 months ago
stalled on sema, tried tirz, and the curves were actually different shapes
comment on [Results] 31 weeks on 5mg, full numbers, ask me anything boring in c/compounding · 54 points · 2 months ago
Yeah, 503A and 503B are different regulatory animals.
comment on TB-500 — 11 things I got wrong before I got it right in c/researchpeptides · 23 points · 2 months ago
regulatory status varies by country, check yours
comment on three years of baseline labs threads, summarised so you do not have to read them in c/bloodwork · 23 points · 2 months ago
eGFR noise on rapid loss is real. 22 week noise, 19 week trend. Do not panic at week 7.
196
three years of baseline labs threads, summarised so you do not have to read them
Long-ish post, sorry. tl;dr at the bottom. I have been tracking bloodwork against ApoB for 33 weeks because I could not find anyone who had. The correlation is weaker…
comment on [Meta] proposal — a flair for lean mass posts in c/glp1muscle · 3 points · 3 months ago
[removed by moderator]
Disagree on that part. 96.8% and 96.2% on the same vial is normal.
comment on what changed for me between week 15 and week 58 in c/tirzepatide · 15 points · 3 months ago
the muscle cramps from tirz is different, not necessarily worse
comment on [Question] 503A — what am I missing here in c/compounding · 3 points · 3 months ago
the Poland situation is different from the US, different regulations
comment on [Question] Australia — has anyone got a straight answer on dual agonist in c/tirzepatide · 225 points · 4 months ago
Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.
comment on the co-agonism question that gets asked weekly, answered properly in c/cagrilintide · 12 points · 4 months ago
the mechanism is different, the side effect profile reflects it